Jonathan Howlett
0000-0002-0535-9771
4 papers found
Refreshing results…
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice
Missing publications? Search for publications with a matching author name.